Bryn Mawr Capital Management’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.94M Buy
22,889
+48
+0.2% +$3.85K 0.08% 156
2026
Q1
$1.91M Sell
22,841
-3,754
-14% -$283K 0.09% 153
2025
Q4
$1.78M Buy
26,595
+211
+0.8% +$13.6K 0.09% 157
2025
Q3
$1.78M Sell
26,384
-359
-1% -$26K 0.09% 159
2025
Q2
$1.99M Sell
26,743
-1,412
-5% -$94.1K 0.11% 147
2025
Q1
$1.77M Sell
28,155
-10,743
-28% -$664K 0.11% 146
2024
Q4
$2.22M Hold
38,898
0.12% 144
2024
Q3
$2.29M Sell
38,898
-195
-0.5% -$10.6K 0.12% 141
2024
Q2
$2.11M Buy
39,093
+128
+0.3% +$7.05K 0.12% 147
2024
Q1
$2.25M Sell
38,965
-201
-0.5% -$10.4K 0.13% 140
2023
Q4
$1.88M Sell
39,166
-20,430
-34% -$974K 0.12% 152
2023
Q3
$3.05M Buy
59,596
+43,299
+266% +$2.29M 0.2% 103
2023
Q2
$934K Buy
16,297
+396
+2% +$23.1K 0.09% 170
2023
Q1
$959K Sell
15,901
-51
-0.3% -$3.12K 0.1% 166
2022
Q4
$938K Buy
+15,952
New +$1.01M 0.1% 162

Other funds holding CTVA

Bryn Mawr Capital Management's CTVA Position: Q2 2026 in Review

Bryn Mawr Capital Management increased its Corteva (CTVA) stake by 0.21% in Q2 2026, buying an estimated $3.85K and bringing the position to 22,889 shares worth $1.94M. The position accounts for 0.08% of the portfolio, ranked #156.

Bryn Mawr Capital Management first reported a position in CTVA in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.05M in Q3 2023. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Bryn Mawr Capital Management held 22,889 shares of Corteva worth $1.94M as of Q2 2026.
  • Bryn Mawr Capital Management bought 48 Corteva shares in Q2 2026, an estimated $3.85K.
  • Corteva made up 0.08% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #156 holding.
  • Bryn Mawr Capital Management first reported a position in Corteva in Q4 2022 and has held it in 15 quarters since.
  • Bryn Mawr Capital Management's Corteva position peaked at $3.05M in Q3 2023.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.